Kadimastem Ltd.

Kadimastem Ltd. is a pioneering biotechnology research company focused on developing and manufacturing innovative cell-based therapies. With a cutting-edge technology platform, Kadimastem is dedicated to providing off-the-shelf treatments for critical indications, including Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. The company is located at Pinhas Sapir 7, Nes Ziona, Israel 74140.

Kadimastem's commitment to advancing medical science is reflected in its ongoing clinical trials and its expertise in cell production, bio-banking, and GMP facilities. By leveraging its profound understanding of stem cells, human beta cells, and human oligodendrocytes, Kadimastem is at the forefront of developing therapies that aim to significantly improve patient outcomes and quality of life. Kadimastem’s innovative approach positions it as a key player in the biotechnology sector, striving to address unmet medical needs.

Kadimastem invites you to explore the potential of its groundbreaking research and technology platform. We are actively expanding our collaborations and partnerships to further enhance our impact on global healthcare. The company's management is currently finalizing additional details to provide a comprehensive overview of our advancements and future initiatives. We encourage the manager of Kadimastem to create a customized and exclusive company showcase and product listing on our platform.